MCG
AGN

Meru Capital Group’s Allergan plc AGN Stock Holding History

Meru Capital Group’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-43,299
Closed -$9.97M – 64
2016
Q3 		$9.97M Sell
43,299
-18,000
-29% -$4.4M 2.78% 14
2016
Q2 		$14.2M Sell
61,299
-42,200
-41% -$9.73M 4.91% 8
2016
Q1 		$27.7M Sell
103,499
-12,101
-10% -$3.46M 9% 4
2015
Q4 		$36.1M Buy
115,600
+46,600
+68% +$13.9M 11.21% 3
2015
Q3 		$18.8M Buy
+69,000
New +$21.2M 4.89% 7
2014
Q2 		– Sell
-19,000
Closed -$3.91M – 64
2014
Q1 		$3.91M Buy
+19,000
New +$3.76M 1.02% 30

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Meru Capital Group's AGN Position: Q4 2016 in Review

Meru Capital Group sold out of Allergan plc (AGN) in Q4 2016, closing a stake of 43,299 shares — an estimated $9.97M sold.

Meru Capital Group first reported a position in AGN in Q1 2014 and held it in 6 quarters. The position peaked at $36.1M in Q4 2015. 1,091 funds tracked by Wall St. Rank hold AGN as of Q4 2016.

  • Meru Capital Group reported no remaining Allergan plc position as of Q4 2016 after selling out during the quarter.
  • Meru Capital Group sold 43,299 Allergan plc shares in Q4 2016, an estimated $9.97M.
  • Meru Capital Group first reported a position in Allergan plc in Q1 2014 and held it in 6 quarters.
  • Meru Capital Group's Allergan plc position peaked at $36.1M in Q4 2015.
  • 1,091 funds tracked by Wall St. Rank held Allergan plc as of Q4 2016.

Based on Meru Capital Group's 13F filing for Q4 2016, filed 13 Feb 2017.